Literature DB >> 19691170

Medicare program; prospective payment system and consolidated billing for skilled nursing facilities for FY 2010; minimum data set, version 3.0 for skilled nursing facilities and Medicaid nursing facilities. Final rule.

.   

Abstract

This final rule updates the payment rates used under the prospective payment system (PPS) for skilled nursing facilities (SNFs), for fiscal year (FY) 2010. In addition, it recalibrates the case-mix indexes so that they more accurately reflect parity in expenditures related to the implementation of case-mix refinements in January 2006. It also discusses the results of our ongoing analysis of nursing home staff time measurement data collected in the Staff Time and Resource Intensity Verification project, as well as a new Resource Utilization Groups, version 4 case-mix classification model for FY 2011 that will use the updated Minimum Data Set 3.0 resident assessment for case-mix classification. In addition, this final rule discusses the public comments that we have received on these and other issues, including a possible requirement for the quarterly reporting of nursing home staffing data, as well as on applying the quality monitoring mechanism in place for all other SNF PPS facilities to rural swing-bed hospitals. Finally, this final rule revises the regulations to incorporate certain technical corrections.

Mesh:

Year:  2009        PMID: 19691170

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  2 in total

1.  Thrombolysis with intravenous tissue plasminogen activator predicts a favorable discharge disposition in patients with acute ischemic stroke.

Authors:  Nneka L Ifejika-Jones; Nusrat Harun; Nareesa A Mohammed-Rajput; Elizabeth A Noser; James C Grotta
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

2.  Incremental cost of postacute care in nursing homes.

Authors:  William D Spector; Maria Rhona Limcangco; Heather Ladd; Dana Mukamel
Journal:  Health Serv Res       Date:  2010-10-28       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.